Melius Raises Broadcom Price Target to $475

Analyst: Ben Reitzes 1 min read Reproduced verbatim
Rating
Buy
Target
$475
from $415 (+14%)
Outcome
Reached
on June 2, 2026
Melius Research and Broadcom logos

What the analyst said

Melius analyst Ben Reitzes raised the price target on Broadcom Limited (NASDAQ: AVGO) to $475 (from $415) while maintaining a Buy rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AVGO trades at $326. The 21 analysts who set a target in the last 3 months range from $400 to $630, with a median of $515. This $475 target is 8% below the median.

Since the note AVGO has moved −8% (from $354). The 12-month window closed on October 27, 2026.

Track record

This call✓ Target reached on June 2, 2026, 7 months after the note.

Firm track recordMelius Research: 67% of its 9 targets at least a year old were reached within 12 months; on Broadcom, 2 of 2. Accuracy ranking →

Melius Research on Broadcom

Melius Research price targets on Broadcom

2 calls from May 28, 2025 to October 27, 2025. The target went from $283 to $475 (+68%). The rating stayed Buy.

Melius Research targetAVGO share price
  1. October 27, 2025 This noteTarget raised from $283 (+68%)Buy$475
  2. May 28, 2025Earliest call shownBuy$283
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.